CAMBRIDGE, Mass.—Genzyme Corp. announced June 16 that it has found a virus that impairs cell growth in one of six bioreactors at its Allston Landing manufacturing facility. ...More
WASHINGTON—Enzyme replacement therapy with agalsidase alfa helps preserve kidney function in men with Fabry disease, and the results improve when treatment started early, according to a study published online in the Journal of the American Society of Nephrology. ...More